Related Experiment Video
Updated: Jan 20, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Long noncoding RNA LINC00511 promotes cell growth and invasion in triple-negative breast cancer by interacting with
Ruilei Liu1, Liang Wang2, Tianyu Gan1
1Department of Thyroid and Breast Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Abstract:
Purpose: Aberrant long noncoding RNA expression has been frequently reported in cancer research, including in triple-negative breast cancer (TNBC). The aim of the present study was to investigate the involvement of LINC00511 in the progression and prognosis of TNBC. Materials and methods: The expression level of LINC00511 was examined by RT-PCR in TNBC tissues and in cell lines. MTT and colony formation assays were used to examine the cell growth ability. A Boyden assay was used to examine the cell invasion ability. RNA pull-down and RNA immunoprecipitation (RIP) assays were used to examine the proteins that interacted with LINC00511. Results: We demonstrated that the LINC00511 expression level was elevated in TNBC tissues when compared with that in normal breast tissues. The downregulation of LINC00511 decreased TNBC cell growth and invasion compared to those of the controls. To explore the molecular mechanisms underlying the biological activity of LINC00511, we identified proteins that bound to LINC00511 with RNA pull-down experiments. We showed that LINC00511 binds to the β-transducin repeat containing (BTRC) E3 ubiquitin protein. Mechanistically, LINC00511 maintained the stability of Snail by impeding its ubiquitination and degradation by the BTRC E3 ubiquitin protein. Conclusion: Our data suggested that LINC00511 might serve as a novel molecular target for the treatment of TNBC.
Insights
Long noncoding RNA LINC00511 is elevated in triple-negative breast cancer (TNBC). Downregulating LINC00511 inhibits TNBC cell growth and invasion, suggesting it as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant expression of long noncoding RNAs (lncRNAs) is implicated in various cancers.
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic options.
- The role of specific lncRNAs, like LINC00511, in TNBC progression requires further investigation.
Purpose of the Study:
- To investigate the expression and functional role of LINC00511 in triple-negative breast cancer (TNBC).
- To explore the underlying molecular mechanisms by which LINC00511 influences TNBC progression.
Main Methods:
- Quantitative reverse transcription PCR (RT-PCR) to assess LINC00511 expression in TNBC tissues and cell lines.
- In vitro assays including MTT, colony formation, and Boyden assays to evaluate cell growth and invasion.
- RNA pull-down and RNA immunoprecipitation (RIP) assays to identify proteins interacting with LINC00511.
Main Results:
- LINC00511 expression was significantly upregulated in TNBC tissues compared to normal breast tissues.
- Downregulation of LINC00511 suppressed TNBC cell proliferation and invasion.
- LINC00511 was found to bind to the E3 ubiquitin ligase β-transducin repeat containing (BTRC).
- LINC00511 stabilizes Snail by inhibiting its ubiquitination and degradation mediated by BTRC.
Conclusions:
- LINC00511 plays a crucial role in promoting the progression of triple-negative breast cancer.
- The LINC00511/BTRC/Snail axis represents a potential therapeutic target for TNBC treatment.
Related Concept Videos
The Eukaryotic Promoter Region
RNA Polymerase II Accessory Proteins
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....
Negative Regulator Molecules

